These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18537518)

  • 21. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
    Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G;
    Arthritis Res Ther; 2018 Jan; 20(1):17. PubMed ID: 29382380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic management of systemic sclerosis].
    Mouthon L; Berezné A; Poiraudeau S; Guillevin L
    Presse Med; 2006 Dec; 35(12 Pt 2):1975-82. PubMed ID: 17159724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous HSCT in systemic sclerosis: a step forward.
    Farge D; Gluckman E
    Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic interventions in systemic sclerosis.
    van den Hoogen FH
    Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of complications associated with systemic sclerosis.
    Moore SC; Desantis ER
    Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of scleroderma renal crisis: State of the art.
    Zanatta E; Polito P; Favaro M; Larosa M; Marson P; Cozzi F; Doria A
    Autoimmun Rev; 2018 Sep; 17(9):882-889. PubMed ID: 30005860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systemic sclerosis: symptomatic treatment].
    Dziankowska-Bartkowiak B; Waszczykowska E; Skretkowicz K
    Pol Merkur Lekarski; 2003 Sep; 15(87):259-62. PubMed ID: 14679853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?].
    Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D
    Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile systemic sclerosis: experience from a tertiary care center from India.
    Bagri NK; Raj D; Kaur J; Punia H; Saini I; Lodha R; Kabra SK
    Rheumatol Int; 2017 Oct; 37(10):1687-1691. PubMed ID: 28831595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials for pediatric scleroderma.
    Rosenkranz ME; Lehman TJ
    Curr Rheumatol Rep; 2002 Dec; 4(6):449-51. PubMed ID: 12427357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evidence-based therapy of systemic sclerosis].
    Genth E
    Z Rheumatol; 2001 Dec; 60(6):464-8. PubMed ID: 11826742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
    Strange G; Nash P
    Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FAST.
    Fathi N; Furst DE; Clements PJ
    Curr Rheumatol Rep; 2007 May; 9(2):144-50. PubMed ID: 17502045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide in systemic sclerosis: light and shadows.
    Vlachoyiannopoulos PG; Ioannidis JP
    Clin Exp Rheumatol; 2004; 22(5):551-2. PubMed ID: 15485005
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive therapy. 1.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.